ilmscore | Prediction Details
"We looked at pharma right in pharma a lot of people are talking about CDMO right lot of people are talking about CDMO and US also spoke about pharma tariffs in Jan but we knew that US is so dependent on India that it's not going to be easily done"
By Finance With Sharan | September 20, 2025 | Correct
From video
Why Trump’s Tariffs Shook India’s Markets & How Modi Turned Russian Oil Into Profit | Shashank Udupa 00:30:36 - 00:30:49
Interpreted Prediction
The Contract Development and Manufacturing Organization (CDMO) segment within the Indian pharmaceutical sector is performing well, and US dependence on India provides a buffer against potential tariffs.
AI Evaluation Notes
Based on recent reports, the Indian CDMO sector is still performing strongly and benefiting from US dependence, suggesting the prediction was generally correct. However, the specific impact of potential tariffs is harder to quantify precisely.

Prediction Details

Topic
Indian Pharmaceutical Sector (CDMO)

Comments

0 comments

Be the first to share your thoughts.

Like this prediction?

Join to make your opinion count.